All of the relevant financial relationships listed for faculty have been mitigated.
Presentations:
10:00 AM – 10:05 AM Eastern Time
Assessing Urate Deposition and Inflammation in the Vasculature of Gout Patients Using Dual Energy Computed Tomography and Positron Emission Tomography Pre and Post Pegloticase- a Pilot Study
Ignite Speaker: Ira Khanna, MD – Mount Sinai Hospital
10:05 AM – 10:10 AM Eastern Time
A Double-Blind, Placebo-Controlled, Ascending Dose Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia
Ignite Speaker: Marc Gurwith, MD – Atom BP
10:10 AM – 10:15 AM Eastern Time
Impact of Colchicine Prophylaxis on Cardiovascular Outcome Among Gout Patients: A Secondary Analysis of CARES Trial
Ignite Speaker: Keigo Hayashi, MPH – Brigham and Women's Hospital
10:15 AM – 10:20 AM Eastern Time
WITHDRAWN
10:20 AM – 10:25 AM Eastern Time
Efficacy and Safety of Allopurinol and Febuxostat in Patients with Gout and Chronic Kidney Disease: A Subgroup Analysis of the STOP Gout Study
Ignite Speaker: Lindsay Helget, MD – University of Nebraska Medical Center
